Read the full stored bill text
ENROLLED
2026
Legislature
SB 816
2026816er
1
2 An act relating to diabetes research; creating s.
3 1004.562, F.S.; establishing the University of Florida
4 Diabetes Institute within the University of Florida
5 College of Medicine; providing the purpose of the
6 institute; providing requirements for the institute;
7 authorizing the institute to administer statewide
8 pilot programs; requiring the institute to maintain a
9 secure repository for deidentified data; authorizing
10 the institute to share deidentified data under certain
11 conditions; authorizing the institute to convene a
12 consortium; providing requirements for the consortium;
13 authorizing the consortium to solicit funding from
14 certain sources for certain purposes; requiring the
15 institute to provide a report to the Governor and the
16 Legislature beginning on a specified date and annually
17 thereafter; providing requirements for the report;
18 providing construction; providing an effective date.
19
20 Be It Enacted by the Legislature of the State of Florida:
21
22 Section 1. Section 1004.562, Florida Statutes, is created
23 to read:
24
1004.5
6
2 University of Florida Diabetes Institute.—
25
(1)
The University of Florida Diabetes Institute is
26
established within the University of
Florida College of Medicine
27
as
a
resource for diabetes research, screening, prevention,
28
treatment, and education. The purpose of the institute is to
29
advance scientific discovery, improve prevention and clinical
30
care, and promote education and outreach related to all forms of
31
diabetes, including type 1 diabetes, type 2 diabetes,
32
gestational diabetes, and related metabolic conditions.
33
(2)
The institute shall do all of the following:
34
(a)
Conduct research to understand the causes, mechanisms,
35
and potential cures for diabetes, including autoimmune, genetic,
36
and environmental factors.
37
(b)
Develop advanced prevention, diagnostic, and treatment
38
strategies to reduce the incidence and complications of diabetes
39
in children and adults.
40
(c)
Provide comprehensive, multidisciplinary clinical care
41
to individuals living with diabetes, including patient and
42
family education, nutrition counseling, mental health support,
43
and disease management resources.
44
(d)
Train and educate health care professionals, including
45
physicians, nurses, dietitians, pharmacists, and scientists, to
46
expand expertise in diabetes care and research.
47
(e)
Establish collaborations with state universities,
48
medical centers, patient advocacy groups, community
49
organizations, and government agencies to enhance care and
50
accelerate progress toward diabetes prevention and cures.
51
(f)
Engage in community-based outreach and education
52
programs to increase awareness, reduce disparities in diabetes
53
outcomes, and promote healthier lifestyles.
54
(3)(a)
The institute may establish and administer statewide
55
pilot programs, including
,
but not limited to
,
population-based
56
diabetes screening, prevention initiatives, and technology
57
driven management tools.
58
(b)
The institute shall maintain a secure data repository
59
to collect, store, and analyze deidentified data for the purpose
60
of advancing diabetes research, prevention, and care.
61
(c)
The institute may provide deidentified data, pursuant
62
to data-sharing agreements, to research collaborators to support
63
ongoing and future scientific investigations.
64
(4)(a)
The institute may convene a statewide
d
iabetes
65
r
esearch and
c
are
c
onsortium composed of clinical and academic
66
experts, health care providers, and patient representatives to
67
coordinate research, share expertise, and develop innovative
68
care models.
69
(b)
The consortium shall
, upon being convened,
be
70
administered at the institute under the direction of the
71
institute’s executive leadership.
72
(c)
The consortium may solicit funding from public,
73
nonprofit, and private sources to expand programs, research
74
initiatives, and community services.
75
(5)
Beginning October 15, 2027, and annually thereafter,
76
the institute shall provide a report to the Governor, the
77
President of the Senate, and the Speaker of the House of
78
Representatives
which includes all of the following
:
79
(a)
Research projects and findings.
80
(b)
Clinical services provided and patient outcomes.
81
(c)
Community outreach and prevention initiatives.
82
(d)
Recommendations for future initiatives.
83
(6) T
his section shall be implemented to the extent of
84
appropriations provided in the annual General Appropriations Act
85
or from other available funds.
86 Section 2. This act shall take effect July 1, 2026.